Skip to content

Screen of DM by OGTT in Subjects Receiving CAG or MDCT for CAD

Screen of Diabetes Mellitus by Oral Glucose Tolerance Test in Subjects Receiving Catheterization or Multi-detector Computed Tomography (MDCT) for Coronary Artery Disease

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01198730
Enrollment
2000
Registered
2010-09-10
Start date
2009-04-30
Completion date
2024-12-31
Last updated
2020-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease, Diabetes Mellitus

Keywords

DM, CAD, Meal tolerance test

Brief summary

To determine the glucose regulation status of patients who were suspected to have CAD in central Taiwan.

Detailed description

It had been reported that high prevalence of IGT (impaired glucose tolerance) and unknown DM (diabetes mellitus) in patients with CAD (coronary artery disease). This study aimed to determine the glucose regulation status of patients who were suspected to have CAD in central Taiwan. In general, patient who were admitted for CAG (coronary angiography) or MDCT without known DM were eligible. After informed consent, OGTT (oral glucose tolerance test) was performed to determine the glucose regulation status. Study participants will be requested to complete questionnaires to assess their risk of diabetes and quality of sleep. Patients who were diagnosed as new DM would be asked to follow up in clinical service with diet control.

Interventions

None listed

Sponsors

Taichung Veterans General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient received CAG or MDCT for suspect CAD * Without DM history

Exclusion criteria

* Known DM * Unstable disease condition * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Diabetes3 monthsBased on OGTT and HbA1c

Secondary

MeasureTime frameDescription
Brain-derived neurotrophic factor3 monthsAn biomarker to link brain and atheroclerosis
Coroanry artery disease3 monthsBased on coronary angiography and medical record
Mortality5 yearsAll-cause and cardiovascular

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026